Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS

BACKGROUND: We explored the effect of teriflunomide on cortical gray matter (CGM) and whole brain (WB) atrophy in patients with clinically isolated syndrome (CIS) from the phase III TOPIC study and assessed the relationship between atrophy and risk of conversion to clinically definite MS (CDMS). MET...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Neurol Disord
Huvudupphovsmän: Zivadinov, Robert, Dwyer, Michael G., Carl, Ellen, Poole, Elizabeth M., Cavalier, Steve, Briassouli, Paraskevi, Bergsland, Niels
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672760/
https://ncbi.nlm.nih.gov/pubmed/33240397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420970754
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk